02500nam 2200541Ia 450 991045891360332120200520144314.01-60805-184-6(CKB)2670000000066023(EBL)864329(OCoLC)708569305(SSID)ssj0000674275(PQKBManifestationID)11461028(PQKBTitleCode)TC0000674275(PQKBWorkID)10645816(PQKB)11282871(MiAaPQ)EBC864329(Au-PeEL)EBL864329(CaPaEBR)ebr10447985(EXLCZ)99267000000006602320060801d2010 uy 0engur|n|---|||||txtccrMicroRNAs & cardiovacular disease[electronic resource] /Zhiguo Wang[S.l.] Bentham e Books[2010]1 online resource (150 p.)Description based upon print version of record.1-60805-332-6 Includes bibliographical references and index.04 Contents; 05 Foreword _Yang B_; 06 Preface; 07 Section I; 09 Chapter 2; 10 Section II; 11 Chapter 3; 12 Chapter 4; 13 Chapter 5; 14 Chapter 6; 15 Section III; 16 Chapter 7; 17 Chapter 8; 18 Chapter 9; 19 Chapter 10; 20 Chapter 11; 21 Section IV; 22 Chapter 12; 23 Chapter 13; 24 Chapter 14; 25 Chapter 15; 26 Chapter 16; 27 Section V; 28 Chapter 17; 29 Chapter 18; 30 IndexMicro RNAs (miRNAs) are known to play an important role in gene expression regulation. Owing to their ever-increasing implications in the control of various biological and pathological processes, miRNAs have now been considered novel biomarkers of various human diseases including, cancer, viral disease, cardiovascular disorders, metabolic disturbances, etc. Unique expression profiles have been associated with specific pathological states. Cardiovascular disease is among the main causes of mortality in developed countries. The pathological process of the heart is associated with altered expressRNACardiovascular systemDiseasesElectronic books.RNA.Cardiovascular systemDiseases.572.8/6Wang Zhiguo925089MiAaPQMiAaPQMiAaPQBOOK9910458913603321MicroRNAs & cardiovacular disease2076264UNINA